StreetInsider.com Pre-Open Movers:
IndyMac Bank (NYSE: IMB) 35% LOWER; IndyMac Shut Down Due To Bank Run, FDIC Takes Over
Cardiome Pharma Corp.
(NASDAQ: CRME) 30% HIGHER; announced positive clinical results from its 90-day Phase 2b study of vernakalant (oral).
Cardiome Pharma said the final analysis demonstrated statistically significant efficacy for the patient group receiving 500mg b.i.d. of vernakalant (oral) as compared to placebo.
The safety data from the final analysis also shows that vernakalant (oral) was well-tolerated in the...
Post new comment